FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a key

Company profile

Protalix BioTherapeutics, Inc. Insider Trading

PLX

Every SEC Form 4 insider trading filing for Protalix BioTherapeutics, Inc. (PLX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
CIK
0001006281
Filings
27
Insiders
11
Last filing
2025-12-19
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on December 19, 2025, when Bashan Dror bought 56,000 shares. 27 filings from 11 insiders are on record below.

Quarterly balance

Buy and sell value by quarter, Q3 23 to Q4 25. Protalix BioTherapeutics, Inc. insiders are net buyers across the period shown.

Q3 23Q4 23Q3 24Q2 25Q3 25Q4 25

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $206K.

No insider activity recorded for PLX in the last 90 days.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue1d1w1m3m6m
Dec 19, 2025Bashan DrorPLX
Purchase
56,000$1.81$101K+1.1%+2.9%+17.7%+20.6%+31.4%
Nov 18, 2025Bar-Shalev AmosPLX
Sale
168$1.87$314-1.7%+3.4%-2.3%+77.4%+18.6%
Sep 3, 2025Bar-Shalev AmosPLX
Award
15,000——-3.1%+9.4%+52.8%+8.2%+64.8%
Sep 3, 2025Bar-Shalev AmosPLX
Award
7,500——-3.1%+9.4%+52.8%+8.2%+64.8%
Sep 3, 2025Bashan DrorPLX
Award
195,000——-3.1%+9.4%+52.8%+8.2%+64.8%

33 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=PLX" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Schwartz Aharon1 filing+$206K
Bashan DrorPresident and CEO3 filings+$192K
Bar-Shalev Amos1 filing−$314

Institutional Ownership

Top 13F-HR holders of Protalix BioTherapeutics, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$14.6M
QoQ change
-58.9%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$6.7M
2.9M shares
#2
State Street Corp
CIK 0000093751
$2.3M
984K shares
#3
BlackRock, Inc.
CIK 0002012383
$1.8M
784K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.METAMeta Platforms, Inc.RCGRENN Fund, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/